Metribolone (Methyltrenbolone, R1881)
Experimental anabolic steroid used as a lab reference compound; not studied in people and very damaging to the liver.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is Metribolone (Methyltrenbolone, R1881)?
Metribolone (R1881) is an experimental compound, a modified version of the anabolic steroid trenbolone. It has not been approved as a medicine anywhere, it is treated as a controlled or banned substance in many countries, and no medical study in humans has ever been carried out with it. In laboratories it is used under the name R1881: it is the reference substance for studies of the androgen receptor (the protein that binds male hormones), because it binds to it very strongly and stably.
The chemical change that makes it work by mouth also puts a very heavy load on the liver: even among oral steroids, metribolone is one of the most liver-damaging. It completely shuts down the body's own testosterone production, and recovery can take a long time. It worsens cholesterol values, can raise blood pressure, and can cause aggression, irritability and sleep problems. It must not be used in pregnancy, because it causes masculinization of the fetus. It is banned in competitive sport all year round.
What it actually is
17-alpha-methylated trenbolone derivative; in laboratories, the AR reference ligand known as R1881.
Human clinical trials
None. Never developed for human therapeutic use.
Main risk
Severe hepatotoxicity from the 17-alpha-methyl group, alongside complete HPTA suppression.
Receptor binding
Exceptionally strong and stable androgen receptor binding, which is why it became a laboratory reference.
Legal status
Not a medicine. WADA-banned year-round (S1).
No anecdote collected yet.
Data console
Lab data
Luderschmidt C, Jawny J, Eiermann W . Relative binding affinity at metribolone androgenic binding sites of various antiandrogenic agents.. Arzneimittel-Forschung.
Brinkmann AO, Kuiper GG, de Boer W . Characterization of androgen receptors after photoaffinity labelling with [3H]methyltrienolone (R1881).. Journal of steroid biochemistry.
Thevis M, Guddat S, Schänzer W . Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.. Steroids.
Rahnema CD, Lipshultz LI, Crosnoe LE . Anabolic steroid-induced hypogonadism: diagnosis and treatment.. Fertility and sterility.
Safety
Side effects, stop signs, contraindications
Side effects · 4
- Severe liver injury: the 17-alpha-methyl group places this among the most hepatotoxic oral androgens, and at typical use doses rising liver enzymes are the rule rather than the exception.
- Complete HPTA suppression: the extremely strong receptor binding shuts down endogenous testosterone production rapidly and completely, and recovery can be protracted.
- Marked lipid deterioration and rising blood pressure: a drastic fall in HDL cholesterol is characteristic of 17-alpha-alkylated oral androgens.
- Aggression, irritability and sleep disturbance: central nervous system effects commonly reported with trenbolone derivatives.
Contraindications · 5
- Any existing liver disease or elevated baseline ALT/AST: absolute contraindication.
- Concurrent alcohol use or another 17-alpha-alkylated oral steroid: hepatic load is additive.
- Dyslipidemia or existing cardiovascular disease.
- Pregnancy and breastfeeding: androgenic action causes fetal virilization, use is prohibited.
- Competitive sport under testing: WADA bans anabolic androgenic steroids year-round (S1).
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
Relative binding affinity at metribolone androgenic binding sites of various antiandrogenic agents.
Luderschmidt C, Jawny J, Eiermann W
Characterization of androgen receptors after photoaffinity labelling with [3H]methyltrienolone (R1881).
Brinkmann AO, Kuiper GG, de Boer W
Doping control analysis of trenbolone and related compounds using liquid chromatography-tandem mass spectrometry.
Thevis M, Guddat S, Schänzer W
Anabolic steroid-induced hypogonadism: diagnosis and treatment.
Rahnema CD, Lipshultz LI, Crosnoe LE
Telegram
Have a question about Metribolone (Methyltrenbolone, R1881)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.